Early Growth Patterns and Cardiac Structure and Function at Midlife: Northern Finland 1966 Birth Cohort Study - 20/05/20
Abstract |
Objectives |
To evaluate the influence of early growth patterns that have previously been associated with later cardiometabolic risk on cardiac left ventricular (LV) structure and function in midlife.
Study design |
A subpopulation of the Northern Finland Birth Cohort 1966 took part in follow-up, including echocardiography (n = 1155) at the age of 46 years. Body mass index (BMI) growth curves were modeled based on frequent anthropometric measurements in childhood. Age and BMI at adiposity peak (n = 482, mean age 9.0 months) and at adiposity rebound (n = 586, mean age 5.8 years) were determined. Results are reported as unstandardized beta (β) or OR with 95% CIs for 1 SD increase in early growth variable.
Results |
Earlier adiposity rebound was associated with increased LV mass index (β = −4.10 g/m2 (−6.9, −1.3); P = .004) and LV end-diastolic volume index (β = −2.36 mL/m2 (−3.9, −0.84); P = .002) as well as with eccentric LV hypertrophy (OR 0.54 [0.38, 0.77]; P = .001) in adulthood in males. BMI at adiposity rebound was directly associated with LV mass index (β = 2.33 g/m2 [0.80, 3.9]; P = .003). Higher BMI at both adiposity peak and at adiposity rebound were associated with greater LV end-diastolic volume index (β = 1.47 mL/m2; [0.51, 2.4], β = 1.28 mL/m2 [0.41, 2.2], respectively) and also with eccentric LV hypertrophy (OR 1.41 [1.10, 1.82], OR 1.53 [1.23, 1.91], respectively) and LV concentric remodeling (OR 1.38 [1.02, 1.87], OR 1.40 [1.06, 1.83], respectively) in adulthood (P < .05 for all). These relationships were only partly mediated by adult BMI.
Conclusions |
Early growth patterns in infancy and childhood contribute to cardiac structure at midlife.
Le texte complet de cet article est disponible en PDF.Keywords : left ventricular structure, left ventricular mass, left ventricular hypertrophy, childhood growth, body mass index, adiposity rebound
Abbreviations : BMI, E/e', LA, LV, LVEF, LVM, NFBC, RWT, SES
Plan
Supported by the Academy of Finland (no. 285547), Finnish Foundation for Cardiovascular Research, European Union's Horizon 2020 research and innovation program (633595, EU H2020-PHC-2014 633595, DynaHEALTH, EU H2020-SC1-2016-2017, LIFECYCLE, EU H2020-HCO-2014, iHEALTH), Yrjö Jahnsson Foundation, Aarne Koskelo Foundation, and Oulu University Scholarship Foundation. NFBC1966 received financial support from University of Oulu (no. 24000692), Oulu University Hospital (no. 24301140), and ERDF European Regional Development Fund (no. 539/2010 A31592). Sponsors had no role in study design, the collection, analysis or interpretation of the data, writing of the report or the decision to submit the manuscript for publication. The authors declare no conflicts of interest. |
|
Portions of this study were presented at the European Society of Cardiology Congress, August 31-September 4, 2019, Paris, France. |
Vol 221
P. 151 - juin 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?